Paper12697290
No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease.
Monastero R and 10 others. Neurosci Lett, 2003. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease. Papers, record 12697290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12697290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Dipeptides | Major topic |
| Nitric Oxide Synthase | Major topic |
| Polymorphism, Genetic | Major topic |
| Aged | |
| Aged, 80 and over | |
| Case-Control Studies | |
| Chi-Square Distribution | |
| Female | |
| Humans | |
| Italy | |
| Male | |
| Middle Aged | |
| Nitric Oxide Synthase Type III |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34035901 | Nitride oxide synthase 3 and klotho gene polymorphisms in the pathogenesis of chronic kidney disease and age-related cognitive impairment: a systematic review and meta-analysis. | F1000Res | 2020 | https://conductscience.org/library/papers/34035901 | PubMed |
| 32508326 | Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabút Aging Project. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/32508326 | PubMed |
| 26337484 | The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26337484 | PubMed |
| 21607713 | The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline. | Neuromolecular Med | 2011 | https://conductscience.org/library/papers/21607713 | PubMed |
| 20607039 | Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. | Int J Clin Exp Med | 2010 | https://conductscience.org/library/papers/20607039 | PubMed |
| 18183499 | Association between Alzheimer's disease and the NOS3 gene Glu298Asp polymorphism in Chinese. | J Mol Neurosci | 2008 | https://conductscience.org/library/papers/18183499 | PubMed |
| 15940388 | Association of the endothelial nitric oxide synthase (NOS3) Glu298Asp gene polymorphism with the risk of Alzheimer's disease-- a meta-analysis. | J Neurol | 2005 | https://conductscience.org/library/papers/15940388 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| NOS3 | 4846 | PubTator's text mining | https://conductscience.org/library/genes/4846 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12697290
GET https://conductscience.org/api/papers/v1/12697290/authors